Tenax Therapeutics
TENX
12 hedge funds and large institutions have $119K invested in Tenax Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.25% less ownership
Funds ownership: 0.27% → 0.02% (-0.25%)
48% less capital invested
Capital invested by funds: $231K → $119K (-$111K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$6.67K |
| 2 |
Millennium Management
New York
|
+$5.52K |
| 3 |
HF
HRT Financial
New York
|
+$3.87K |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$1.68K |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$39K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$20.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7.74K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$213 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Corient Private Wealth
Miami,
Florida
| $57.4K | – | – | – |
|
2
State Street
Boston,
Massachusetts
| $28.5K | – | – | – |
|
3
BlackRock
New York
| $7.18K | – | – | – |
|
|
4
LPL Financial
San Diego,
California
| $6K | +$6.67K | +250 | New |
|
|
TSS
5
Two Sigma Securities
New York
| $5.93K | -$7.74K | -290 | -54% |
|
|
6
Millennium Management
New York
| $4.97K | +$5.52K | +207 | New |
|
|
APP
7
Avantax Planning Partners
Dubuque,
Iowa
| $4.5K | +$1.68K | +63 | +50% |
|
|
HF
8
HRT Financial
New York
| $3K | +$3.87K | +145 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1.4K | -$213 | -8 | -12% |
|
10
Morgan Stanley
New York
| $205 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $47 | +$27 | +1 | +100% |
|
|
AF
12
Allworth Financial
Folsom,
California
| $1 | – | – | – |
|
|
TAM
13
Tucker Asset Management
Littleton,
Colorado
| $1 | – | – | – |
|
|
VF
14
Virtu Financial
New York
| – | -$39K | -1,055 | Closed |
|
|
15
Verition Fund Management
Greenwich,
Connecticut
| – | -$20.3K | -545 | Closed |
|
|
BCV
16
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | +$27 | +1 | New |
|
TENX Hedge Fund Activity: Q2 2023 in Review
12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2023, worth a combined $119K — down 48% from $231K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TENX positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was LPL Financial, opening a new position worth an estimated $6.67K. The largest seller was Virtu Financial, exiting entirely with an estimated $39K sold.
- 12 institutional investors held Tenax Therapeutics (TENX) as of Q2 2023, up from 10 in Q1 2023.
- Funds reported $119K of Tenax Therapeutics stock for Q2 2023, down 48% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q2 2023 and 2 closed out, a net change of +2 holders.
- The largest Tenax Therapeutics buyer in Q2 2023 was LPL Financial, an estimated $6.67K added.
- The largest Tenax Therapeutics seller in Q2 2023 was Virtu Financial, an estimated $39K sold.
Based on aggregated 13F filings for Q2 2023.